Integrative Research Laboratories Sweden AB
Developing novel CNS drugs for Parkinson's disease using proprietary technology.
Overview
- 20–49
- Employees
- 100–500M SEK
- Revenue
- 2013
- Founded
Key Decision Makers
Kristina Torfgård
CEO
Anders Vedin
Chairman of the Board
Hans-Peter Ostler
Board Member
Clas Sonesson
Chief Scientific Officer
+14 more contacts in Funnelfeedr
Description
IRLAB Therapeutics AB is a rapidly growing, publicly traded biotechnology company headquartered in Gothenburg, Sweden. The organization is dedicated to transforming life for people suffering from Parkinson’s disease and other Central Nervous System (CNS) disorders. IRLAB utilizes its unique, proprie...